It is a non-invasive system to decrease the blood flow of a targeted organ in case of bleeding or a medical requirement.
Very large market potential. It will be primarily used to increase the survival chance of wounded people in battle field as well as accidents. The system will have uses for surgical operations as well.
• Fellowship, 2006, Harvard Medical School
• Fellowship, 2006, Stanford University, School of Medicine
• PhD., 2005, Marmara University, School of Medicine
• MD, 2001, Uludag University, School of Medicine
We are considering start-up option and looking for equity investors. The technology can be considered for sale or out-licensing as well.
|Field||:||Biotechnology and Health|
|For more information||:||firstname.lastname@example.org|